CareCloud, Inc.

NASDAQ:CCLD

Medical - Healthcare Information Services

Healthcare
$2.38 +1.60%

+$0.04 today

Market cap
$101.27M
Beta
1.51
P/E (TTM)
9.7
EPS (TTM)
$0.23
52W Low $2.09High $4.01

Volume 0.53M

Average 0.58M

CCLD Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

CareCloud, Inc.NASDAQ: CCLD

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense grows, but more slowly than its trailing trend

Q1 FY2026 income tax expense of $52K rose 26.8% year over year, behind the +29.6% change in trailing-twelve-month income tax expense. Sequentially, it fell 28.8% from the prior quarter. Over 3 fiscal years it compounded at +4.0% a year.

Context

  • Income tax expense amounted to 0.2% of revenue in FY2025, unchanged from a year earlier.
  • Income tax expense increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +26.8% toward the trailing-twelve-month pace of +29.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$52K-28.8% QoQ
Last fiscal yearDec 2025
$199K+24.4% YoY
LTMMar 2026
$210K+29.6% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+26.8%——
1 year+24.4%——
3-year CAGR+4.0%——
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
199K USD
Year-over-year change
+24.4%
4-year CAGR
+6.1%

Income Tax Expense vs competitors

How CCLD compares with its peers on the latest reported figures

  • CCLD's LTM Mar 2026 income tax expense of $210K is the 2nd highest of the 10 companies compared; the peer median is $0.
  • Its year-over-year change of +29.6% is the 4th highest of 5, against a peer median of +52.2%.
  • Income tax expense amounts to 0.2% of revenue for CCLD, versus a peer median of 0.1%.
CCLD Competitors Peer median
Income Tax Expense for CCLD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
APYXApyx Medical CorporationLTM Mar 2026$364K +46.8%-9.7%0.7%
CCLDCareCloud, Inc.LTM Mar 2026$210K +29.6%+4.0%0.2%
SEERSeer, Inc.LTM Mar 2026$110K -44.7%—0.7%
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026$41K +57.7%—0.1%
JYNTThe Joint Corp.LTM Mar 2026$36.36K +113.4%-17.3%0.1%
IRDOpus Genetics, Inc.LTM Mar 2026$0 ——0.0%
AGENAgenus Inc.LTM Mar 2026$0 ——0.0%
TTRXTurn Therapeutics Inc.LTM Mar 2026$0 ———
HURATuHURA Biosciences, Inc.LTM Mar 2026$0 ———
LUCDLucid Diagnostics Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding CCLD) $0+52.2%-13.5%0.1%

Competitors are the stored peer set for CCLD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue139.6M138.83M117.06M110.84M120.5M
Cost of Revenue86.92M84.43M70.82M60.84M64.46M
Gross Profit52.68M54.39M46.24M50M56.04M
Gross Margin37.7%39.2%39.5%45.1%46.5%
Research & Development4.41M4.4M4.74M3.78M6.38M
Selling, General & Admin33.06M33.61M31.11M22.36M23.2M
Operating Expenses49.15M47.78M93.36M40.87M44.55M
Depreciation & Amortization16.25M15.01M16.55M16.14M16.98M
EBITDA19.7M21.03M(31.29M)25.05M28.26M
EBITDA Margin14.1%15.1%-26.7%22.6%23.5%
Operating Income3.53M6.61M(47.12M)9.12M11.5M
Operating Margin2.5%4.8%-40.2%8.2%9.5%
Interest Income15K41K154K88K206K
Interest Expense455K405K1.19M900K287K
Other Income / Expenses(536K)(1M)(1.92M)(1.11M)(500K)
Income Before Tax2.99M5.61M(49.04M)8.01M11M
Pre-Tax Margin2.1%4.0%-41.9%7.2%9.1%
Income Tax Expense157K177K(364K)160K199K
Net Income2.84M5.43M(48.67M)7.85M10.8M
Net Margin2.0%3.9%-41.6%7.1%9.0%
EPS (Basic)(0.77)(0.67)(4.11)(0.28)0.10
EPS (Diluted)(0.77)(0.67)(4.11)(0.28)0.10
Weighted Avg Shares14.54M15.11M15.67M16.15M377.92M
Weighted Avg Shares (Diluted)14.54M15.11M15.67M16.15M379.54M

CareCloud, Inc.

NASDAQ:CCLD

Intrinsic Alpha fair value

Locked

Current Price

$2.38

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.